Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.

Julia C Hews-GirardNatalia RydzAdrienne LeeMarilyn Dawn GoodyearMan-Chiu Poon

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2018)

Based on our review, we suggest that the determination of desmopressin responsiveness should consider both the change in plasma FVIII levels as well as clinical outcomes associated with prior therapeutic use.

Keyphrases

molecularly imprinted
solid phase extraction
drug induced